Search results
Found 1083 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
Coronavirus COVID-19 General Research
9 June 2022
People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology with the involvement of researchers from the University of Oxford.
Collaborative team driven by DPAG and Chemistry awarded RSC Horizon Prize
Awards and Appointments General Research
7 June 2022
The Molecular Flow Sensor Team, with collaborating members principally from DPAG’s Robbins and Talbot groups and the Department of Chemistry, has been named the winner of the Royal Society of Chemistry’s (RSC) Analytical Division Horizon Prize for the development of a new technology for measuring lung function.
Oxford expands the Cartography collaboration with Janssen
General Innovation Research
6 June 2022
The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation
Doctoral research funding initiative launched to tackle antimicrobial resistance
Funding Opportunities General Research
1 June 2022
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
Museum of Natural History to showcase Science Together community-researcher collaborations
General Research
1 June 2022
Explore Science Together event at the Oxford University Museum of Natural History on Tuesday 7 June.
Long COVID: vaccination could reduce symptoms, new research suggests
Coronavirus COVID-19 General Research
27 May 2022
While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.
Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds
Coronavirus COVID-19 General Research
26 May 2022
Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.
Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
Coronavirus COVID-19 General Research
24 May 2022
COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
Tinnitus seems linked with sleep – understanding how could bring us closer to finding a cure
General Research
23 May 2022
New reporting guidelines developed to improve AI in healthcare settings
General Research
19 May 2022
New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.
Major boost for Oxford’s mission to counter future pandemic threats
General Research
19 May 2022
The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.
Three NHSBT research units launch at University of Oxford
Awards and Appointments General Research
18 May 2022
The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.
Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study
Coronavirus COVID-19 General Research
16 May 2022
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.
COVID-19’s high blood clot risk
Coronavirus COVID-19 General Research
14 May 2022
A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.
Medical Sciences Division receives REF 2021 results
General Research
12 May 2022
Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.
Oxford researchers part of major UK initiative to understand chronic pain
General Research
10 May 2022
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Neither detection nor control of high blood pressure improved by self-monitoring during pregnancy
General Research
4 May 2022
Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from the University of Oxford and King’s College London (funded by the National Institute of Health and Care Research).
Breakthrough in treatment for Dupuytren’s disease
Clinical Trials General Research
30 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
How to use the science of the body clock to improve our sleep and health
General Research
28 April 2022
Jacqueline Pumphrey, April 2022
Paediatric IBD BioResource opens to support vital research
General Research
28 April 2022
A new National Institute for Health and Care Research (NIHR) BioResource aimed at investigating inflammatory bowel disease (IBD) in children has opened, with the NIHR Oxford BRC playing a key role.